STRATELYON GROUP
ActiveSummary
STRATELYON GROUP has been active since 2008 and the Belgian State Gazette contains no insolvency signals. The CBE does carry 2 administrative register entries (see administrative flags). The 2025 annual accounts show equity of €1.9m and a net result of €1.5m. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 91% of 527 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 1.2% (low).
Checked score
Score 2025
Axes · tick = 2024
Profitability100▲+54
Solvency100▲+53
Growth78=
Track record84
Bankruptcy probability, 12 months
1.2%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €140,000 at 30 days acceptable
Liquidity ample (current ratio 32.01 against 1.27 in 2024; short-term debt: 3% and cash: 0.4% of total assets), and 4.6% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Nine signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
95.4%
Return on assets
73.6%
Age of the figures
9 mo
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 72
Relative position
BE, all sectors
reference
Scientific research and development (NACE 72)
about 30% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
lowers risk · Growing equity
Reported equity is higher than in 2023 and did not fall compared with 2024. These amounts do not establish the cause of the change.
NBB · annual accounts 2025Equity per financial year
1819202122232425
2018 to 2025 · latest year €1.9m
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-08-2026, 31 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
31 d late
2024
60 d late
2023
31 d late
2022
31 d late
2021
31 d late
2020
31 d late
2019
185 d late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 57 days after the deadline; the sector median for financial year 2024 is 13 days before the deadline, and 32% of the sector filed late.
raises risk · Administrative warnings in the KBO publications
2 publications by the FPS Economy about this company, such as a strike-off for address, accounts or UBO, or their withdrawal.
KBO publicationsPublications
Address struckAddress strikeout annulled
Checked, nothing found (1)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 31 August (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven monthsPosition in the running window
29-09-2026 today31-12-2026 close31-07-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, micro schema
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€1.5m▲ 2,175%
2024 · €64,409
Working capital
€1.9m▲ 364%
2024 · €402,660
Trend over the years
Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 72, Scientific research and development, each year against the same schema; no band under 30 filings. Dashed line: the median.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Operating result-€12,071€11,336€9,318▼ 17.8%€62,470▲ 570%-€26,964
Net result€4.6mabove the sector's middle half€3.0mabove the sector's middle half▼ 35.6%€188,544above the sector's middle half▼ 93.7%€64,409within the sector's middle half▼ 65.8%€1.5mabove the sector's middle half▲ 2,175%
Equity€149,725within the sector's middle half€179,447within the sector's middle half▲ 19.9%€367,991within the sector's middle half▲ 105%€432,400within the sector's middle half▲ 17.5%€1.9mabove the sector's middle half▲ 339%
Total assets€4.7mabove the sector's middle half▲ 171%€3.3mwithin the sector's middle half▼ 29.6%€894,147within the sector's middle half▼ 72.8%€2.0mwithin the sector's middle half▲ 118%€2.0mabove the sector's middle half▲ 2.0%
Debt€4.5m▲ 152%€3.1m▼ 31.2%€526,156▼ 83.1%€1.5m▲ 189%€92,019▼ 93.9%
Working capital€117,342within the sector's middle half€117,937within the sector's middle half▲ 0.5%€799,531within the sector's middle half▲ 578%€402,660within the sector's middle half▼ 49.6%€1.9mabove the sector's middle half▲ 364%
Solvency3.2%below the sector's middle half▲ 7.5pp5.4%below the sector's middle half▲ 2.2pp41.2%within the sector's middle half▲ 35.7pp22.2%within the sector's middle half▼ 19.0pp95.4%above the sector's middle half▲ 73.2pp
Current ratio1.03below the sector's middle half▲ 0.081.04below the sector's middle half▲ 0.0125.15above the sector's middle half▲ 24.111.27within the sector's middle half▼ 23.8832.01above the sector's middle half▲ 30.74
Return on assets (ROA)98.9%above the sector's middle half▲ 98.9pp90.5%above the sector's middle half▼ 8.4pp21.1%above the sector's middle half▼ 69.4pp3.3%within the sector's middle half▼ 17.8pp73.6%above the sector's middle half▲ 70.3pp
Staff (FTE)1=1below the sector's middle half=1below the sector's middle half=1below the sector's middle half=
above
within
below
the middle half (P25 to P75) of NACE 72, Scientific research and development, each year against the same schema; no band under 30 filings.
Why a figure moved sharply
- 2025 Net result +2,175% on 2024. The accounts now follow the micro schema, last year the full schema.
Result per fiscal year
Operating resultNet result
The operating result turns negative in 2025: a loss of €26,964 after €62,470 in 2024, the lowest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €2.0m
Fixed assets
€61,510 =
Current assets
€1.9m ▲ 2.0%
Equity and liabilities €2.0m
Equity
€1.9m ▲ 339%
Debt
€92,019 ▼ 93.9%
Debt's share of the balance-sheet total falls from 77.8% to 4.6%. Equity is higher and debt is lower.
Key figures and ratios
Debt to equity
0.05▼
2024 · 3.51
ROE
77.2%▲
2024 · 14.9%
Debt ≤ 1 year
€60,250▼
2024 · €1.5m
Staff costs
€3,941▼
2024 · €92,094
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 17,810 companies that looked in July 2024 the way this one looks now, 0.2% went bankrupt within 24 months and 97% are still going.
- Small
- 10 to 20 years old
- solvency 30% or more
- a profit of 5% of the balance sheet or more
0.2%
went bankrupt
3.1%
stopped otherwise
97%
still going
For this company itself Checked computes a higher bankruptcy probability: 1.2% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,662 companies of July 2024 its group's bankruptcy share. Expected: 1.5%; actually bankrupt within 24 months: 1.6%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.4% |
| 3 | 0.5% | 0.5% |
| 4 | 0.6% | 0.7% |
| 5 | 0.8% | 0.9% |
| 6 | 1.2% | 1.3% |
| 7 | 1.5% | 1.7% |
| 8 | 1.7% | 1.7% |
| 9 | 2.7% | 2.8% |
| 10 | 5.3% | 5.7% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 75% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 17,810 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Remuneration, social security and pensions62 | €67,696 | €92,921 | €104,717 | €92,094 | €3,941 | ▼ 95.7% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €112 | - | - | - | - | - |
| Other operating charges640/8 | €868 | €868 | €960 | - | €1,038 | - |
| Gross operating margin9900 | €56,605 | €105,125 | €114,996 | €154,564 | -€21,985 | ▼ 114% |
| Operating profit (loss)9901 | -€12,071 | €11,336 | €9,318 | €62,470 | -€26,964 | ▼ 143% |
| Financial income75/76B | €4.6m | €3.0m | €188,474 | €40,198 | €1.5m | ▲ 3,613% |
| Recurring financial income75 | €4.6m | €3.0m | €188,474 | €40,198 | €1.5m | ▲ 3,613% |
| Financial charges65/66B | €3,282 | €1,288 | €9,248 | €32,059 | €74 | ▼ 99.8% |
| Recurring financial charges65 | €3,282 | €1,288 | €9,248 | €32,059 | €74 | ▼ 99.8% |
| Profit (loss) for the period before taxes9903 | €4.6m | €3.0m | €188,544 | €70,609 | €1.5m | ▲ 1,976% |
| Income taxes67/77 | - | - | - | €6,200 | - | - |
| Profit (loss) for the period9904 | €4.6m | €3.0m | €188,544 | €64,409 | €1.5m | ▲ 2,175% |
| Profit (loss) for the period to be appropriated9905 | €4.6m | €3.0m | €188,544 | €64,409 | €1.5m | ▲ 2,175% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €4.7m | €3.3m | €894,147 | €2.0m | €2.0m | ▲ 2.0% |
| Fixed assets21/28 | €32,383 | €61,510 | €61,510 | €61,510 | €61,510 | = |
| Financial fixed assets28 | €32,383 | €61,510 | €61,510 | €61,510 | €61,510 | = |
| Current assets29/58 | €4.6m | €3.2m | €832,637 | €1.9m | €1.9m | ▲ 2.0% |
| Amounts receivable within one year40/41 | €4.2m | €2.5m | €716,219 | €1.9m | €1.9m | ▲ 2.6% |
| Trade receivables40 | €9,841 | €63,841 | €9,841 | €47,841 | €9,841 | ▼ 79.4% |
| Other amounts receivable41 | €4.1m | €2.4m | €706,378 | €1.8m | €1.9m | ▲ 4.7% |
| Current investments50/53 | €84 | - | - | - | - | - |
| Cash at bank and in hand54/58 | €487,737 | €763,581 | €116,418 | €18,716 | €8,942 | ▼ 52.2% |
| Deferred charges and accrued income490/1 | €469 | €304 | - | - | - | - |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €4.7m | €3.3m | €894,147 | €2.0m | €2.0m | ▲ 2.0% |
| Equity10/15 | €149,725 | €179,447 | €367,991 | €432,400 | €1.9m | ▲ 339% |
| Contributions10/11 | €6,200 | €6,200 | €6,200 | €6,200 | €6,200 | = |
| Reserves13 | €1,860 | €1,860 | €1,860 | €1,860 | €1,860 | = |
| Non-distributable reserves130/1 | €1,860 | €1,860 | €1,860 | €1,860 | €1,860 | = |
| Reserves not available under the articles1311 | €1,860 | €1,860 | €1,860 | €1,860 | €1,860 | = |
| Profit (loss) carried forward14 | €141,665 | €171,387 | €359,931 | €424,340 | €1.9m | ▲ 345% |
| Amounts payable17/49 | €4.5m | €3.1m | €526,156 | €1.5m | €92,019 | ▼ 93.9% |
| Amounts payable after more than one year17 | - | - | €493,050 | - | - | - |
| Other amounts payable178/9 | - | - | €493,050 | - | - | - |
| Amounts payable within one year42/48 | €4.5m | €3.1m | €33,106 | €1.5m | €60,250 | ▼ 96.0% |
| Financial debts43 | €441 | €441 | €441 | €441 | €441 | = |
| Credit institutions430/8 | €441 | €441 | €441 | €441 | €441 | = |
| Trade debts44 | €41,589 | €80,876 | €7,710 | €8,368 | €38,186 | ▲ 356% |
| Suppliers440/4 | €41,559 | €26,846 | €7,710 | €8,368 | €38,186 | ▲ 356% |
| Bills of exchange payable441 | €30 | €54,030 | - | - | - | - |
| Taxes, remuneration and social security45 | €54,036 | €16,603 | €17,822 | €18,339 | €14,180 | ▼ 22.7% |
| Taxes450/3 | €46,221 | €5,627 | €5,115 | €18,339 | €14,180 | ▼ 22.7% |
| Remuneration and social security454/9 | €7,815 | €10,976 | €12,706 | - | - | - |
| Other amounts payable47/48 | €4.4m | €3.0m | €7,134 | €1.5m | €7,444 | ▼ 99.5% |
| Accrued charges and deferred income492/3 | - | - | - | €31,770 | €31,770 | = |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €4.6m | €3.0m | €188,544 | €64,409 | €1.5m | ▲ 2,175% |
| + Depreciation and write-downs630 | €112 | - | - | - | - | - |
| Operating cash flow (approximation) | €4.6m | €3.0m | €188,544 | €64,409 | €1.5m | ▲ 2,175% |
| Investment in fixed assets (approximation) | - | -€29,127 | €0 | €0 | €0 | - |
| Change in cash | - | €275,844 | -€647,163 | -€97,701 | -€9,775 | ▲ 90.0% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
31-08
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema · 31 days late
2025
31-12
Financial
Liquidity times 25current ratio 32.01
Current ratio from 1.27 to 32.01; short-term debt falls from €1.5m to €60,250.
31-12
Financial
Equity above €1mEq €1.9m ▲339%
5 profitable years in a row build equity to €1.9m.
29-09
NBB filing
Annual accounts filed
fiscal year 2024 · full schema · 60 days late
07-05
KBO administration
Address strikeout annulled
17-01
KBO administration
Address struck
2024
31-08
NBB filing
Annual accounts filed
fiscal year 2023 · full schema · 31 days late
2023
31-12
Financial
Liquidity times 24current ratio 25.15
Current ratio from 1.04 to 25.15; short-term debt falls from €3.1m to €33,106.
31-12
Financial
Equity above €200,000Eq €367,991 ▲105%
3 profitable years in a row build equity to €367,991.
31-08
NBB filing
Annual accounts filed
fiscal year 2022 · full schema · 31 days late
2022
31-12
Financial
Equity above €150,000Eq €179,447 ▲19.9%
2 profitable years in a row build equity to €179,447.
31-08
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 31 days late
Show earlier events
2021
31-12
Financial
Back to profitnet €4.6m
Net result €4.6m after 3 loss-making years.
31-12
Financial
Equity above €100,000Eq €149,725
Equity rises from -€73,848 to €149,725.
31-08
NBB filing
Annual accounts filed
fiscal year 2020 · full schema · 31 days late
01-02
NBB filing
Annual accounts filed
fiscal year 2019 · full schema · 185 days late
2019
30-08
NBB filing
Annual accounts filed
fiscal year 2018 · full schema · 30 days late
2018
29-08
NBB filing
Annual accounts filed
fiscal year 2017 · full schema · 29 days late
2017
31-07
NBB filing
Annual accounts filed
fiscal year 2016 · full schema
SignalFinancial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 9 acts read
About the unread acts
We know of 9 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
9 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Jette · 1 establishment unit since 2008
Ground area
3,017 m²
Building footprint
1,607 m²
Volume, LiDAR
22,276 m³
2 parcels, Brussels, Wallonia · tallest building 17.7 m, ±5 floors. Linked by address, not a title deed.
14
companies at this address
See who is registered here
1 establishment unit
4 Clinics Group
since 20082.174.264.601
2 parcels
Wallonia
1
(50%)
Brussels
1
(50%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 25110B0610/00F000 | Wallonia | 1,823 m² | 1 · 594 m² | 16.9 m · 5 fl. |
| 21464D0173/00A000 | Brussels | 1,195 m² | 1 · 1,013 m² | 17.7 m · 5 fl. |
Linked by address, not proof of ownership
Good to know
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
NANOCYL
BE 0476.998.785
Sambreville · Eq €1,892,398
S-Biomedic
BE 0668.407.105
Gent · Eq €1,853,688
Dr.T.Braeckevelt – klinische biologie
BE 0884.531.419
Ronse · Eq €1,837,033
JOHAN WILLEMSE
BE 0830.295.848
Kasterlee · Eq €1,963,067
CoreAalst
BE 0755.485.389
Aalst · Eq €1,963,531
Of 1,177 companies in sector 72109 we hold annual accounts for 717. 402 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded20-10-2008
Fiscal year end31-12
Activities, NACEBEL 2025
72109Other research and development on natural sciences
70200Business and other management consultancy
73300Public relations and communication consultancy
82100Office administrative and support services
E-invoicing
Reachable via Peppol
Peppol ID
0208:0807210442
Also
9925:BE0807210442
Registered
13-04-2026
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 28 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.